 |
All Publications of Dr. Petricoin III |
Showing
results 11 to 20 of 23 |
| |
Next
>>
|
| Opportunities for nanotechnology-based innovation in tissue proteomics |
| D Geho N Lahar M Ferrari E Petricoin III L Liotta |
| Biomed Microdevices
2004 6
231 |
| |
| Novel approaches to visualization and data mining reveals diagnostic information in the low amplitude region of serum mass spectra from ovarian cancer patients. |
| D Johann M McGuigan S Tomov V Fusaro S Ross T Conrads T Veenstra D Fishman G Whiteley E Petricoin III L Liotta |
| Dis Markers
2003 19
197 |
| |
| Mitochondrial proteome: Altered cytochrome c oxidase subunit levels in prostate cancer. |
| P Herrmann J Gillespie L Charboneau V Bichsel C Paweletz V Calvert E Kohn M Emmert-Buck L Liotta E Petricoin III |
| Proteomics.
2003 3
1801 |
| |
| Counterpoint: The vision for a new diagnostic paradigm |
| E Petricoin III L Liotta |
| Clin Chem.
2003 49
1276 |
| |
| Cancer diagnosis using proteomic patterns. |
| T Conrads M Zhou E Petricoin III L Liotta T Veenstra |
| Expert Rev Mol Diagn.
2003 3
411 |
| |
| Clinical applications of proteomics |
| E Petricoin III L Liotta |
| J Nutr.
2003 133
2476S |
| |
| Protein microarrays: Meeting analytical challenges for clinical applications. |
| L Liotta V Espina A Mehta V Calvert K Rosenblatt D Geho P Munson L Young J Wulfkuhle E Petricoin III |
| Cancer Cell.
2003 3
317 |
| |
| Proteomic applications for the early detection of cancer. |
| J Wulfkuhle L Liotta E Petricoin III |
| Nat Rev Cancer
2003 3
267 |
| |
| Mass spectrometry-based diagnostics: the upcoming revolution in disease detection. |
| E Petricoin III L Liotta |
| Clin Chem
2003 49
533 |
| |
| The granulin-epithelin precursor/PC-cell-derived growth factor is a growth factor for epithelial ovarian cancer. |
| M Jones C Michener J Blanchette V Kuznetsov M Raffeld G Serrero M Emmert-Buck E Petricoin III Krizman L Liotta E Kohn |
| Clin Cancer Res.
2003 9
44 |
| |